Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ureaplasma urealyticum chorioamnionitis

C F Maher1, M V Haran, D J Farrell

  • 1Department of Obstetrics and Gynaecology, Toowoomba Base Hospital, Queensland.

The Australian & New Zealand Journal of Obstetrics & Gynaecology
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CPHLN recommendations for the laboratory detection of Shiga toxin-producing <i>Escherichia coli</i> (O157 and non-O157).

Canada communicable disease report = Releve des maladies transmissibles au Canada·2019
Same author

Surgical management of pelvic organ prolapse.

Climacteric : the journal of the International Menopause Society·2018
Same author

Gepotidacin (GSK2140944) <i>In Vitro</i> Activity against Gram-Positive and Gram-Negative Bacteria.

Antimicrobial agents and chemotherapy·2017
Same author

<i>In Vitro</i> Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae.

Antimicrobial agents and chemotherapy·2017
Same author

Plate augmentation for femoral nonunion: more than just a salvage tool?

Archives of orthopaedic and trauma surgery·2015
Same author

Wedge effect following intramedullary hip screw fixation of intertrochanteric proximal femur fracture.

Archives of orthopaedic and trauma surgery·2015
Same journal

Determining the Feasibility of a No-Ultrasound Screening Tool for Early Medical Abortion in Australia.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

'All In': Equitable Health Outcomes Require Culturally Safe Care for Everybody.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Benzylpenicillin Concentrations in Intrapartum Group B Streptococcus Prevention Guidelines; A Systematic Review of the Evidence.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Retrospective Cohort Study of Foetal Growth Restricted Births After 40 Weeks at an Australian Tertiary Maternity Hospital Between 2018 and 2021.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Models of Antenatal Care for Rural Indigenous Women: A Systematic Review.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005-2020.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
See all related articles

Ureaplasma urealyticum infection is linked to adverse pregnancy outcomes like chorioamnionitis and premature birth. This study details four cases of Ureaplasma urealyticum chorioamnionitis, highlighting associated infant morbidity and mortality.

Area of Science:

  • Reproductive Medicine
  • Microbiology
  • Perinatology

Background:

  • Ureaplasma urealyticum is a common bacterium in the urogenital tract.
  • Its role in pregnancy complications remains debated.
  • Chorioamnionitis is an infection of the fetal membranes.

Observation:

  • This study presents four clinical cases.
  • All cases involved Ureaplasma urealyticum infection of the chorioamnion.
  • These infections were associated with significant adverse outcomes.

Findings:

  • Ureaplasma urealyticum chorioamnionitis was observed in all four cases.
  • The infections were linked to premature birth.
  • Significant perinatal morbidity and mortality were documented.

Related Experiment Videos

Implications:

  • These findings underscore the potential pathogenic role of Ureaplasma urealyticum in pregnancy.
  • Early detection and management of Ureaplasma urealyticum may be crucial for improving perinatal outcomes.
  • Further research is warranted to clarify diagnostic and therapeutic strategies.